Equative: quality of life in adult patients with short bowel syndrome treated by teduglutide, a french real-world study

F Joly,E Fontaine,D Seguy,C Chambrier,V Campana,D Quilliot,N Flori,E Ressiot,S Schneider,G Fotsing,N Schmidely,F Poullenot,R Thibault,S Layec

doi:10.1016/j.clnesp.2021.09.346

Equative: quality of life in adult patients with short bowel syndrome treated by teduglutide, a french real-world study

F Joly, E Fontaine + Show 12 more

https://doi.org/10.1016/j.clnesp.2021.09.346

Copy DOI

#Life In Adult Patients #Short Bowel Syndrome + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Rationale: Short bowel syndrome with intestinal failure (SBS-IF) requires use of parenteral support (PS) and highly impacts patients (pts) quality of life (QoL). Teduglutide (TED), a GLP-2-analog, has proven efficacy reducing the need for PS. The study aimed to compare QoL in French TED vs non-TED pts.

Full Text